Literature DB >> 14986660

[Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].

A Eckstein1, J Esser.   

Abstract

Mesh：

Year:  2003        PMID： 14986660     DOI： 10.1007/s00347-003-0873-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  69 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial.

Authors:  G J Kahaly; H P Rösler; S Pitz; G Hommel
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

Review 3.  Radioiodine and the immune system.

Authors:  L J DeGroot
Journal:  Thyroid       Date:  1997-04       Impact factor: 6.568

4.  High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy.

Authors:  Ritva Kauppinen-Mäkelin; Anni Karma; Eeva Leinonen; Eliisa Löyttyniemi; Oili Salonen; Timo Sane; Kirsi Setälä; Jorma Viikari; Armin Heufelder; Matti Välimäki
Journal:  Acta Ophthalmol Scand       Date:  2002-06

Review 5.  Neuroradiological diagnosis in thyroid-associated orbitopathy.

Authors:  W Müller-Forell; S Pitz; W Mann; G J Kahaly
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

6.  Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy.

Authors:  J A Garrity; V Fatourechi; E J Bergstralh; G B Bartley; C W Beatty; L W DeSanto; C A Gorman
Journal:  Am J Ophthalmol       Date:  1993-11-15       Impact factor: 5.258

7.  Natural history of thyroid associated ophthalmopathy.

Authors:  P Perros; A L Crombie; P Kendall-Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  1995-01       Impact factor: 3.478

8.  Optic nerve involvement in dysthyroidism.

Authors:  J D Trobe
Journal:  Ophthalmology       Date:  1981-06       Impact factor: 12.079

9.  Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.

Authors:  M F Prummel; W M Wiersinga; M P Mourits; L Koornneef; A Berghout; R van der Gaag
Journal:  Arch Intern Med       Date:  1990-05

10.  Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?

Authors:  L Tallstedt; G Lundell; H Blomgren; J Bring
Journal:  Eur J Endocrinol       Date:  1994-05       Impact factor: 6.664
View more
  6 in total

1.  [Diagnosis and differential diagnosis of Graves' orbitopathy in MRI].

Authors:  D Daubner; S Spieth; K Engellandt; R von Kummer
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

2.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

3.  [Protrusio bulbi].

Authors:  B Sadowski; R Wöhrle; N Wöhrle; K Helmke
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

4.  [Unilateral exophthalmos?].

Authors:  A Büttner; M P Schittkowski
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

5.  [Endocrine ophthalmopathy. A visible psychophysical complaint].

Authors:  I Strempel
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

6.  Medial Rectus Tendon Elongation with Bovine Pericard (Tutopatch®) in Thyroid-Associated Orbitopathy: A Long-Term Follow-Up including Oculodynamic MRI.

Authors:  Monika Wipf; Britt-Isabelle Berg; Anja Palmowski-Wolfe
Journal:  J Ophthalmol       Date:  2018-07-24       Impact factor: 1.909
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.